He is zooming in on topical preparations

According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting ap...

Marie Gårdmark: Potential step change – EU regulators get to play with data

to the outcome of the pilot to hopefully then understand if “in house” analyses actually will add value.

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

Visar upp ny gammakniv

Elekta presenterar sin nya produkt Leksell Gamma Knife Icon för strålkirurgi av hjärnan vid en konferens i Barcelona.

Business Sweden’s new team is rolling out the blue-yellow carpet

According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...

Första gammakniven till Asien

Får in de första beställningarna på sitt nyligen CE-märkta system Leksell Gamma Knife Icon för kraniell strålkirurgi.

Levererar till Karolinska

Elekta tar emot order från Karolinska Universitetssjukhuset.

Elekta tar genväg

Får snabbare godkännande för sitt strålkirurgisystem i USA.

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

Add Bio får tre nya ägare

Tar in 9,4 miljoner kronor i nyemission.

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Elekta når inte förväntningarna

Strålterapibolaget publicerar en svag rapport från det tredje kvartalet.

Elekta i dollartungt samarbetsavtal

Elekta och GenesisCare tecknar strategiskt samarbetsavtal till ett värde om mer än 100 miljoner USD.

Norway finds its path in life science

The life science sector in Norway is on the rise.

Femte förslaget till regeringen från SwedenBio

Skärp målsättningen för deltagandet i EU:s ramprogram. Det är SwedenBios femte förslag inför den kommande forskningspropositionen.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Product Specialist at Gradientech AB, Uppsala